Beckwith Samira 4
4 · Tabula Rasa HealthCare, Inc. · Filed Nov 14, 2023
Insider Transaction Report
Form 4
Beckwith Samira
Director
Transactions
- Disposition to Issuer
Common Stock
2023-11-03−62,658→ 25,641 total - Disposition to Issuer
Common Stock
2023-11-03−25,641→ 0 total - Disposition to Issuer
Stock Option (Right to Buy)
2023-11-03$4.68/sh−257$1,203→ 0 totalExercise: $5.82Exp: 2025-01-01→ Common Stock (257 underlying)
Footnotes (3)
- [F1]Upon the consummation of the merger (the "Merger") contemplated by that certain Agreement and Plan of Merger, by and among Tabula Rasa HealthCare, Inc. (the "Company"), Locke Buyer, LLC and Locke Merger Sub, Inc., dated August 5, 2023 (the "Merger Agreement"), 62,658 shares of common stock of the Company ("Common Stock") were converted into the right to receive a cash payment of $657,909, representing the product obtained by multiplying (x) the aggregate number of shares of Common Stock owned by the reporting person, by (y) the offer price ($10.50).
- [F2]Upon the consummation of the Merger, pursuant to the Merger Agreement, 25,641 unvested restricted stock awards ("RSAs") were cancelled and converted into the right to receive a cash payment of $269,230.50, representing the product obtained by multiplying (x) the aggregate number of shares of Common Stock underlying the RSAs, by (y) the offer price ($10.50).
- [F3]Upon the consummation of the Merger, pursuant to the Merger Agreement, 257 stock options (the "Options") were cancelled and converted into the right to receive a cash payment of $1,202.76, representing the product obtained by multiplying (x) the aggregate number of shares of Common Stock underlying the Options, by (y) the amount by which the offer price ($10.50) exceeds the per share exercise price of the Options.